Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: A prospective cohort study

Arthritis Research and Therapy

Volumn 16, Issue 4, 2014, Pages

  Tansley, Sarah L ^a   Betteridge, Zoe E ^b   Gunawardena, Harsha ^c   Jacques, Thomas S ^d   Owens, Catherine M ^e   Pilkington, Clarissa ^e   Arnold, Katie ^e,f   Yasin, Shireena ^f   Moraitis, Elena ^e   Wedderburn, Lucy ^e   McHugh, Neil J ^a   McCann, Liza ^g   Roberts, Ian ^g   Baildam, Eileen ^g   Hanna, Louise ^g   Lloyd, Olivia ^g   Riley, Phil ^h   McGovern, Ann ^h   Ryder, Clive ⁱ   Scott, Janis ⁱ   Wyatt, Sue ^j   Jackson, Gillian ^j   Amin, Tania ^j   Wood, Mark ^j   VanRooyen, Vanessa ^j   Davidson, Joyce ^k   Gardner Medwin, Janet ^k   Martin, Neil ^k   Ferguson, Sue ^k   Waxman, Liz ^k   Friswell, Mark ^l   Foster, Helen ^l   Swift, Alison ^l   Jandial, Sharmila ^l   Stevenson, Vicky ^l   Wade, Debbie ^l   Sen, Ethan ^l   Smith, Eve ^l   Qiao, Lisa ^l   Venning, Helen ^m   Satyapal, Rangaraj ^m   Stretton, Elizabeth ^m   Jordan, Mary ^m   Armon, Kate ⁿ   Ellis Gage, Joe ⁿ   Roper, Holly ⁿ   Hasson, N ^e   Maillard, Sue ^e   Halkon, Elizabeth ^e   Brown, Virginia ^e   Juggins, Audrey ^e   Smith, Sally ^e   Lunt, Sian ^e   Enayat, Elli ^e   Varsani, Hemlata ^e   Beard, Laura ^e   Kassoumeri, Laura ^e   Murray, Kevin ^o   Ioannou, John ^p   Suffield, Linda ^p   more..

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b University of Bath   (United Kingdom)

^c NORTH BRISTOL NHS TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^h ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

ⁱ BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^j LEEDS GENERAL INFIRMARY   (United Kingdom)

^k ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^l Infectious Diseases Allergy   (United Kingdom)

^m QUEEN S MEDICAL CENTRE   (United Kingdom)

ⁿ NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^o PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^p UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; AUTOANTIBODY; MDA5 AUTOANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN;

ARTICLE; BLOOD ANALYSIS; CAUCASIAN; CHILD; CHILDHOOD; CHILDHOOD MYOSITIS ASSESSMENT SCORE; COHORT ANALYSIS; DERMATOMYOSITIS; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; JUVENILE DERMATOMYOSITIS; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUSCLE BIOPSY; MUSCLE DISEASE; MYOSITIS; PHENOTYPE; POLYMYOSITIS; PRESCHOOL CHILD; SKIN ULCER; UNITED KINGDOM; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; CONTROLLED STUDY; DISEASE ACTIVITY; FOLLOW UP; IMMUNOPRECIPITATION; LUNG DISEASE; MUSCLE STRENGTH; ONSET AGE; PAPULE; PROSPECTIVE STUDY; RASH; SCORING SYSTEM; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; IMMUNOLOGY; PATHOLOGY;

AUTOANTIBODIES; AUTOANTIGENS; CHILD; COHORT STUDIES; DEAD-BOX RNA HELICASES; DERMATOMYOSITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; PHENOTYPE;

EID: 84903413902     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4600     Document Type: Article

References (28)

1. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 2009, 48:607-612. 10.1093/rheumatology/kep078, 19439503.
2. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009, 60:2193-2200. 10.1002/art.24621, 19565506.
3. Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, Kawabata D, Ohmura K, Usui T, Fujii T, Okawa K, Mimori T. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 2010, 49:433-440. 10.1093/rheumatology/kep375, 20015976.
4. Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, Takagi K, Baba S, Okamoto Y, Ota Y, Yamanaka H. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology 2012, 51:1563-1570. 10.1093/rheumatology/kes102, 22589330.
5. Koga T, Fujikawa K, Horai Y,AO, Kawashiri S, Iwamoto N, Suzuki T, Nakashima Y, Tamai M, Arima K, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Ishimatsu Y, Mukae H, Kuwana M, Kohno S, Eguchi K, Aoyagi K, Kawakami A. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology 2012, 51:1278-1284. 10.1093/rheumatology/ker518, 22378718.
6. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. J Am Acad Dermatol 2011, 65:25-34. 10.1016/j.jaad.2010.09.016, 3167687, 21531040.
7. Betteridge ZE, Tansley S, Gunawardena H, Wedderburn LR, Chinoy H, Cooper RG, Vencovsky J, Lundberg IE, Plestilova L, Danko K, Vincze M, McHugh NJ. Adult and juvenile dermatomyositis patients with anti-MDA5 autoantibodies [abstract]. Arthritis Rheum 2012, 64(10):S715.
8. Hall JC, Casciola-Rosen L, Samedy L-A, Werner J, Owoyemi K, Danoff SK, Christopher-Stine L. Anti-MDA5-associated dermatomyositis: Expanding the clinical spectrum. Arthritis Care Res 2013, 65:1307-1315.
9. Kobayashi I, Okura Y, Yamada H. Anti-Melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis. J Pediatr 2011, 158:675-677. 10.1016/j.jpeds.2010.11.033, 21232756.
10. Sato S, Kobayashi N, Yamazaki K, Suzuki Y. Clinical Utility of Anti-CADM-140/Melanoma differentiation-associated gene 5 autoantibody titres in patients with juvenile dermatomyositis and rapidly progressive interstitial lung disease [abstract]. Arthritis Rheum 2012, 64(10):S128.
11. Robinson AB, Reed AM. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol 2011, 7:664-675. 10.1038/nrrheum.2011.139, 21947177.
12. Kobayashi I. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology 2002, 42:371-374.
13. Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, Wedderburn LR, . and on behalf of the Juvenile Dermatomyositis Research Group A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology 2011, 50:137-145. 10.1093/rheumatology/keq261, 2999955, 20823094, and on behalf of the Juvenile Dermatomyositis Research Group.
14. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). NEJM 1975, 292:344-347. 10.1056/NEJM197502132920706, 1090839.
15. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, Zemel LS, Wallace CA, Ballinger SH, Passo MH, Reed AM, Summers RM, White PH, Katona IM, Miller FW, Lachenbruch PA, Rider LG, . and for the Juvenile Dermatomyositis Disease Activity Collaborative Study Group Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004, 50:1595-1603. 10.1002/art.20179, 15146430, and for the Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
16. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VPL, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N, . and for the Paediatric Rheumatology International Trials Organisation (PRINTO) The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. ARD 2013, 72:686-693. and for the Paediatric Rheumatology International Trials Organisation (PRINTO).
17. Wedderburn LR, Varsani H, Li CKC, Newton KR, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith A, Harding B, Hoogendijk J, Lundberg IE, Marie S, Minetti C, Nennesmo I, Rushing EJ, Sewry C, Charman SC, Pilkington CA, Holton JL, . and UK Juvenile Dermatomyositis Research Group International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007, 57:1192-1201. 10.1002/art.23012, 17907237, and UK Juvenile Dermatomyositis Research Group.
18. Varsani H, Charman SC, Li CK, Marie SKN, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AME, Sewry C, Pilkington CA, Holton JL, Wedderburn LR. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. ARD 2013, doi: 10.1136/annrheumdis-2013-203396.
19. Sato S, Kuwana M, Fujita T, Suzuki Y. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 2012, 23:496-502.
20. Bendewald MJ. Incidence of Dermatomyositis and Clinically Amyopathic DermatomyositisA Population-Based Study in Olmsted County. Minnesota Arch Dermatol 2010, 146:26.
21. Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD. A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol 2007, 157:637-644. 10.1111/j.1365-2133.2007.08055.x, 17596148.
22. McCann LJ, Li CKC, Varsani H, Wedderburn LR, Pilkington CA. Failure to over express MHC-CLASS-1 on muscle biopsy in a case of amyopathic juvenile dermatomyositis. Clin Exp Rheumatol 2007, 25:96-98.
23. Allenbach Y, Leroux G, Uzuhnan Y, Valeyre D, Saadoun D, Aubart F, Hervier B, Hie M, Wipff J, Myiara M, Charuel JL, Musset L, Audia S, Devillier H, Bonnote B, Barete S, Nimal N, Rigolet A, Herson S, Benveniste O. Dermatomyositis associated with MDA-5 antibodies: Report of the first European series [abstract]. Neuromuscular Disorders 2013, 23(9):813-814.
24. Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T. Anti-MDA5 and anti-TIF1- antibodies have clinical significance for patients with dermatomyositis. Rheumatology 2010, 49:1726-1733. 10.1093/rheumatology/keq153, 20501546.
25. Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Murguia Rice M, Miller FW Rider LG. The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies. Medicine 2013, 92:25-41. 10.1097/MD.0b013e31827f264d, 23263716.
26. Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of Interstitial Lung Diseases. Mayo Clin Proc 2007, 62:976-986.
27. Sanner H, Aalokken TM, Gran JT, Sjaastad I, Johansen B, Flato B. Pulmonary outcome in juvenile dermatomyositis: a case to control study. ARD 2010, 70:86-91.
28. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005, 52:1571-1576. 10.1002/art.21023, 15880816.